Actinium Pharmaceuticals, Inc. (FRA:7AY1)

Actinium Pharmaceuticals Revenue

Actinium Pharmaceuticals had revenue of $90.00K USD in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $90.00K, up 11.11% year-over-year.

• Revenue (ttm): $90.00K
• Revenue Growth: +11.11%
• P/S Ratio: 485.99
• Revenue / Employee: $2.43K
• Employees: 37
• Market Cap: 37.28M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	81.00K	-949.00K	-92.14%
Dec 31, 2022	1.03M	-114.00K	-9.97%
Dec 31, 2021	1.14M	-	-
Dec 31, 2020	-	-	-